Core Scientific Future Growth

Future criteria checks 2/6

Core Scientific is forecast to grow earnings and revenue by 180.6% and 31.2% per annum respectively while EPS is expected to grow by 179.2% per annum.

Key information

180.6%

Earnings growth rate

179.2%

EPS growth rate

IT earnings growth	17.1%
Revenue growth rate	31.2%
Future return on equity	n/a
Analyst coverage	Low
Last updated	28 Nov 2023

Recent future growth updates

Recent updates

Core Scientific: A Solid Bitcoin Mining Play

Oct 11

Core Scientific: A Buy On Leading Bitcoin Production Numbers

Aug 11

Core Scientific July bitcoin production rose 10.4% M/M with new deployments and multiple facilities

Aug 05

Core Scientific signs $100M in committed equity facility for enhancing liquidity

Jul 21

Earnings and Revenue Growth Forecasts

OTCPK:CORZ.Q - Analysts future estimates and past financials data (USD Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
12/31/2024	685	-3	N/A	N/A	2
12/31/2023	475	-52	N/A	N/A	1
9/30/2023	482	-486	14	159	N/A
6/30/2023	531	-879	-46	102	N/A
3/31/2023	568	-1,681	-95	229	N/A
12/31/2022	640	-2,146	-386	205	N/A
9/30/2022	821	-1,651	-195	199	N/A
6/30/2022	771	-1,233	-260	206	N/A
3/31/2022	683	-426	-393	-76	N/A
12/31/2021	544	47	-116	-57	N/A
9/30/2021	266	-16	-294	-172	N/A
6/30/2021	163	-1	-178	-130	N/A
3/31/2021	94	-6	-24	-3	N/A
12/31/2020	60	-23	-25	-24	N/A
12/31/2019	60	-12	-38	-1	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CORZ.Q is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: CORZ.Q is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: CORZ.Q is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: CORZ.Q's revenue (31.2% per year) is forecast to grow faster than the US market (8.1% per year).

High Growth Revenue: CORZ.Q's revenue (31.2% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if CORZ.Q's Return on Equity is forecast to be high in 3 years time

Core Scientific Future Growth

Future criteria checks 2/6

Key information

Recent future growth updates

Price target decreased to US$8.02

Consensus EPS estimates fall by 13%

Price target decreased to US$11.00

Consensus forecasts updated

Core Scientific, Inc. Provides Operating Guidance for the Year 2022

Price target decreased to US$16.19

Recent updates

Core Scientific, Inc. to Report Q1, 2024 Results on May 08, 2024

Core Scientific, Inc. to Report Fiscal Year 2023 Results on Mar 12, 2024

Core Scientific, Inc. Emerged from Bankruptcy

Core Scientific, Inc. Com Deleted from OTC Equity

Modified Fourth Amended Joint Reorganization Plan and Disclosure Statement Approved for Core Scientific, Inc.

Core Scientific, Inc. has completed a Follow-on Equity Offering in the amount of $55 million.

Amended Reorganization Plan Filed by Core Scientific, Inc.

Core Scientific, Inc. has filed a Follow-on Equity Offering in the amount of $55 million.

Core Scientific, Inc. has filed a Follow-on Equity Offering in the amount of $55 million.

Core Scientific, Inc. announced that it expects to receive $53.9 million in funding from Bitmain Technologies Limited

Core Scientific, Inc. Appoints Adam Sullivan as Chief Executive Officer

Core Scientific, Inc. Appoints Adam Sullivan as President

Core Scientific, Inc. announced delayed 10-Q filing

Core Scientific, Inc.(OTCPK:CORZ.Q) dropped from NASDAQ Composite Index

Core Scientific's Common Stock to Be Delisted from Nasdaq

Core Scientific, Inc. Filed for Bankruptcy

Core Scientific Receives A Written Notice from the Listing Qualifications Staff of Nasdaq Regarding Minimum Bid Price Requirement

Stacie Olivares Resigns as A Director of Core Scientific, Inc

Core Scientific, Inc. Appoints Todd Duchene as President and Chief Legal Officer, Effective November 14, 2022

Core Scientific, Inc. announced delayed 10-Q filing

Core Scientific, Inc Contemplates Bankruptcy

Core Scientific, Inc. Announces Management Changes

Core Scientific: A Solid Bitcoin Mining Play

Core Scientific, Inc. announced delayed 10-Q filing

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Core Scientific, Inc. Announces Impairment Charges for the Second Quarter Ended June 30, 2022

Core Scientific: A Buy On Leading Bitcoin Production Numbers

Core Scientific July bitcoin production rose 10.4% M/M with new deployments and multiple facilities

Core Scientific, Inc. announced that it expects to receive $100 million in funding from B. Riley Principal Capital II, LLC

Core Scientific signs $100M in committed equity facility for enhancing liquidity

Price target decreased to US$8.02

Core Scientific, Inc. to Report Q2, 2022 Results on Aug 11, 2022

Consensus EPS estimates fall by 13%

Why I'm Very Optimistic On Core Scientific's Future

Price target decreased to US$11.00

Co-Founder recently sold US$9.0m worth of stock

Consensus forecasts updated

Core Scientific, Inc. Provides Operating Guidance for the Year 2022

Price target decreased to US$16.19

Investor sentiment deteriorated over the past week

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Investor sentiment deteriorated over the past week

Robust Earnings May Not Tell The Whole Story For Core Scientific (NASDAQ:CORZ)

Core Scientific, Inc. announced that it expects to receive $75 million in funding from B. Riley Commercial Capital, LLC

Core Scientific Posts 3849% EBITDA Growth And Bitcoin Holdings Worth ~$400M

Core Scientific, Inc. Announces CFO Changes

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies